HNF4A and SREBF1 |
hepatocyte nuclear factor 4, alpha |
sterol regulatory element binding transcription factor 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- RORA activates circadian gene expression
|
|
|
|
|
HNF4A and SREBF2 |
hepatocyte nuclear factor 4, alpha |
sterol regulatory element binding transcription factor 2 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Regulation of cholesterol biosynthesis by SREBP (SREBF)
- PPARA activates gene expression
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- Transcriptional regulation of white adipocyte differentiation
- Activation of gene expression by SREBF (SREBP)
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
|
|
|
|
|
HNF4A and MED14 |
hepatocyte nuclear factor 4, alpha |
mediator complex subunit 14 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- PPARA activates gene expression
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- Generic Transcription Pathway
- Transcriptional regulation of white adipocyte differentiation
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
|
|
|
|
|
HNF4A and PPARGC1A |
hepatocyte nuclear factor 4, alpha |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- PPARA activates gene expression
- Organelle biogenesis and maintenance
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- REV-ERBA represses gene expression
- RORA activates circadian gene expression
- Mitochondrial biogenesis
- Activation of PPARGC1A (PGC-1alpha) by phosphorylation
- Transcriptional regulation of white adipocyte differentiation
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
- Transcriptional activation of mitochondrial biogenesis
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
|
|
|
|
|
HNF4A and MED21 |
hepatocyte nuclear factor 4, alpha |
mediator complex subunit 21 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- PPARA activates gene expression
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- Transcriptional regulation of white adipocyte differentiation
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
|
|
|
|
|
HNF4A and NCOA1 |
hepatocyte nuclear factor 4, alpha |
nuclear receptor coactivator 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- PPARA activates gene expression
- Bile acid and bile salt metabolism
- Defective CYP2R1 causes Rickets vitamin D-dependent 1B (VDDR1B)
- Organelle biogenesis and maintenance
- Metabolism of lipids and lipoproteins
- Metabolic disorders of biological oxidation enzymes
- Phase 1 - Functionalization of compounds
- Defective CYP27B1 causes Rickets vitamin D-dependent 1A (VDDR1A)
- RORA activates circadian gene expression
- Regulation of cholesterol biosynthesis by SREBP (SREBF)
- Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
- Generic Transcription Pathway
- Defective CYP2U1 causes Spastic paraplegia 56, autosomal recessive (SPG56)
- Cytochrome P450 - arranged by substrate type
- Endogenous sterols
- Transcriptional regulation of white adipocyte differentiation
- Biological oxidations
- Synthesis of bile acids and bile salts
- Orphan transporters
- Defective FMO3 causes Trimethylaminuria (TMAU)
- Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)
- Fatty acid, triacylglycerol, and ketone body metabolism
- Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)
- Defective CYP27A1 causes Cerebrotendinous xanthomatosis (CTX)
- Defective CYP11B1 causes Adrenal hyperplasia 4 (AH4)
- Recycling of bile acids and salts
- Defective CYP26B1 causes Radiohumeral fusions with other skeletal and craniofacial anomalies (RHFCA)
- REV-ERBA represses gene expression
- Defective CYP1B1 causes Glaucoma
- Defective CYP17A1 causes Adrenal hyperplasia 5 (AH5)
- Mitochondrial biogenesis
- Defective CYP7B1 causes Spastic paraplegia 5A, autosomal recessive (SPG5A) and Congenital bile acid synthesis defect 3 (CBAS3)
- Defective CYP19A1 causes Aromatase excess syndrome (AEXS)
- Defective CYP4F22 causes Ichthyosis, congenital, autosomal recessive 5 (ARCI5)
- Defective CYP24A1 causes Hypercalcemia, infantile (HCAI)
- Synthesis of bile acids and bile salts via 27-hydroxycholesterol
- Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
- Defective MAOA causes Brunner syndrome (BRUNS)
- Defective CYP11B2 causes Corticosterone methyloxidase 1 deficiency (CMO-1 deficiency)
- YAP1- and WWTR1 (TAZ)-stimulated gene expression
- Activation of gene expression by SREBF (SREBP)
- Defective CYP21A2 causes Adrenal hyperplasia 3 (AH3)
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
- Transcriptional activation of mitochondrial biogenesis
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
|
|
|
|
|
HNF4A and NRIP1 |
hepatocyte nuclear factor 4, alpha |
nuclear receptor interacting protein 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
|
|
|
|
|
HNF4A and SUMO2 |
hepatocyte nuclear factor 4, alpha |
small ubiquitin-like modifier 2 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- SUMO is proteolytically processed
- Post-translational protein modification
- SUMOylation
- SUMO is conjugated to E1 (UBA2:SAE1)
- SUMO is transferred from E1 to E2 (UBE2I, UBC9)
- Processing and activation of SUMO
|
|
|
|
|
HNF4A and PRMT1 |
hepatocyte nuclear factor 4, alpha |
protein arginine methyltransferase 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Chromatin modifying enzymes
- Chromatin organization
- RMTs methylate histone arginines
|
|
|
|
|
HNF4A and PROX1 |
hepatocyte nuclear factor 4, alpha |
prospero homeobox 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
|
|
|
|
|
HNF4A and NPPA |
hepatocyte nuclear factor 4, alpha |
natriuretic peptide A |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Amyloids
- Generic Transcription Pathway
- YAP1- and WWTR1 (TAZ)-stimulated gene expression
|
|
|
|
|
HNF4A and NCOA6 |
hepatocyte nuclear factor 4, alpha |
nuclear receptor coactivator 6 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- PPARA activates gene expression
- Organelle biogenesis and maintenance
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- REV-ERBA represses gene expression
- RORA activates circadian gene expression
- Mitochondrial biogenesis
- Regulation of cholesterol biosynthesis by SREBP (SREBF)
- Generic Transcription Pathway
- Transcriptional regulation of white adipocyte differentiation
- Activation of gene expression by SREBF (SREBP)
- YAP1- and WWTR1 (TAZ)-stimulated gene expression
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
- Transcriptional activation of mitochondrial biogenesis
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- Orphan transporters
|
|
|
|
|
HNF4A and PNRC2 |
hepatocyte nuclear factor 4, alpha |
proline-rich nuclear receptor coactivator 2 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
|
|
|
|
|
HNF4A and XPO1 |
hepatocyte nuclear factor 4, alpha |
exportin 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Loss of Function of TGFBR2 in Cancer
- Downregulation of TGF-beta receptor signaling
- SMAD2/3 MH2 Domain Mutants in Cancer
- Signaling by Wnt
- TGF-beta receptor signaling activates SMADs
- Influenza Life Cycle
- Export of Viral Ribonucleoproteins from Nucleus
- RNF mutants show enhanced WNT signaling and proliferation
- Regulation of mRNA stability by proteins that bind AU-rich elements
- TGFBR2 MSI Frameshift Mutants in Cancer
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
- Host Interactions of HIV factors
- Loss of Function of SMAD4 in Cancer
- TGFBR1 KD Mutants in Cancer
- Influenza Infection
- Late Phase of HIV Life Cycle
- Resolution of Sister Chromatid Cohesion
- Mitotic G2-G2/M phases
- Mitotic Metaphase and Anaphase
- Mitotic Prometaphase
- Separation of Sister Chromatids
- HIV Infection
- Rev-mediated nuclear export of HIV RNA
- G2/M Transition
- Mitotic Anaphase
- TGFBR1 LBD Mutants in Cancer
- HuR stabilizes mRNA
- deactivation of the beta-catenin transactivating complex
- M Phase
- HIV Life Cycle
- Rev-mediated nuclear export of HIV RNA
- Cyclin A/B1 associated events during G2/M transition
- XAV939 inhibits tankyrase, stabilizing AXIN
- NEP/NS2 Interacts with the Cellular Export Machinery
- Loss of Function of SMAD2/3 in Cancer
- TGFBR2 Kinase Domain Mutants in Cancer
- Interactions of Rev with host cellular proteins
- Cell Cycle, Mitotic
- Loss of Function of TGFBR1 in Cancer
- Signaling by TGF-beta Receptor Complex
- Signaling by TGF-beta Receptor Complex in Cancer
- TCF dependent signaling in response to WNT
- Signaling by WNT in cancer
- SMAD4 MH2 Domain Mutants in Cancer
|
|
|
|
|
HNF4A and MAPK3 |
hepatocyte nuclear factor 4, alpha |
mitogen-activated protein kinase 3 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- Signaling by FGFR in disease
- RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
- Cellular Senescence
- ERKs are inactivated
- Signaling by EGFRvIII in Cancer
- Toll Like Receptor TLR1:TLR2 Cascade
- Toll Like Receptor 5 (TLR5) Cascade
- Gastrin-CREB signalling pathway via PKC and MAPK
- MyD88 dependent cascade initiated on endosome
- SOS-mediated signalling
- Fcgamma receptor (FCGR) dependent phagocytosis
- SHC-mediated signalling
- Regulation of actin dynamics for phagocytic cup formation
- TRIF-mediated TLR3/TLR4 signaling
- ERK1 activation
- Senescence-Associated Secretory Phenotype (SASP)
- ERK1 activation
- Signaling by VEGF
- Downstream signal transduction
- Toll Like Receptor 3 (TLR3) Cascade
- Signalling to RAS
- Interleukin-2 signaling
- Platelet activation, signaling and aggregation
- Frs2-mediated activation
- Axon guidance
- IRS-mediated signalling
- L1CAM interactions
- Oncogene Induced Senescence
- VEGFA-VEGFR2 Pathway
- Activated TLR4 signalling
- VEGFR2 mediated cell proliferation
- GRB2 events in ERBB2 signaling
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88:Mal cascade initiated on plasma membrane
- NCAM signaling for neurite out-growth
- RAF/MAP kinase cascade
- Signalling to p38 via RIT and RIN
- Innate Immune System
- Signaling by Insulin receptor
- ERKs are inactivated
- Signal transduction by L1
- Insulin receptor signalling cascade
- ISG15 antiviral mechanism
- Interferon Signaling
- Signaling by Ligand-Responsive EGFR Variants in Cancer
- IRS-related events
- SHC-related events
- Signaling by FGFR
- Thrombin signalling through proteinase activated receptors (PARs)
- ARMS-mediated activation
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Signal attenuation
- Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)
- ERK/MAPK targets
- MAPK targets/ Nuclear events mediated by MAP kinases
- Signaling by GPCR
- FCERI mediated MAPK activation
- SHC1 events in ERBB2 signaling
- Signaling by SCF-KIT
- DAP12 signaling
- Toll Like Receptor 9 (TLR9) Cascade
- ERK/MAPK targets
- Negative regulation of FGFR signaling
- Signaling by PDGF
- DAP12 interactions
- SHC-related events triggered by IGF1R
- GRB2 events in EGFR signaling
- Signaling by ERBB4
- Antiviral mechanism by IFN-stimulated genes
- Toll Like Receptor 2 (TLR2) Cascade
- Signaling by ERBB2
- Signaling by EGFR
- Signaling by Interleukins
- SHC1 events in ERBB4 signaling
- Toll Like Receptor 4 (TLR4) Cascade
- Fc epsilon receptor (FCERI) signaling
- Signaling by EGFR in Cancer
- Growth hormone receptor signaling
- Signaling by Leptin
- Signalling to ERKs
- Prolonged ERK activation events
- ERK activation
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- RNA Polymerase I Promoter Clearance
- IGF1R signaling cascade
- Toll Like Receptor TLR6:TLR2 Cascade
- IRS-related events triggered by IGF1R
- Activation of the AP-1 family of transcription factors
- MyD88 cascade initiated on plasma membrane
- ERK activation
- Downstream signaling of activated FGFR
- Advanced glycosylation endproduct receptor signaling
- Signalling by NGF
- SOS-mediated signalling
- MAP kinase activation in TLR cascade
- RNA Polymerase I Transcription
- SHC-mediated signalling
- Cytokine Signaling in Immune system
- Cellular response to heat stress
- Regulation of HSF1-mediated heat shock response
- NGF signalling via TRKA from the plasma membrane
- MyD88-independent cascade
- Signaling by Overexpressed Wild-Type EGFR in Cancer
- SHC1 events in EGFR signaling
- FRS2-mediated cascade
- IRS-mediated signalling
- Oxidative Stress Induced Senescence
- RNA Polymerase I Promoter Opening
- Nuclear Events (kinase and transcription factor activation)
|
|
- Sulindac
- Arsenic trioxide
- Purvalanol
- 5-iodotubercidin
|
|
|
HNF4A and MED1 |
hepatocyte nuclear factor 4, alpha |
mediator complex subunit 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- PPARA activates gene expression
- Organelle biogenesis and maintenance
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- Nuclear Receptor transcription pathway
- REV-ERBA represses gene expression
- RORA activates circadian gene expression
- Mitochondrial biogenesis
- Regulation of cholesterol biosynthesis by SREBP (SREBF)
- Generic Transcription Pathway
- Transcriptional regulation of white adipocyte differentiation
- YAP1- and WWTR1 (TAZ)-stimulated gene expression
- Activation of gene expression by SREBF (SREBP)
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
- Transcriptional activation of mitochondrial biogenesis
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- Orphan transporters
|
|
|
|
|
HNF4A and TAF6 |
hepatocyte nuclear factor 4, alpha |
TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 80kDa |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- RNA Polymerase II Promoter Escape
- RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
- RNA Polymerase II Transcription
- HIV Infection
- RNA Polymerase II Pre-transcription Events
- Late Phase of HIV Life Cycle
- HIV Life Cycle
- HIV Transcription Initiation
- RNA Polymerase II Transcription Initiation And Promoter Clearance
- RNA Polymerase II HIV Promoter Escape
- RNA Polymerase II Transcription Initiation
- Transcription of the HIV genome
|
|
|
|
|
HNF4A and MED17 |
hepatocyte nuclear factor 4, alpha |
mediator complex subunit 17 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- PPARA activates gene expression
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- Generic Transcription Pathway
- Transcriptional regulation of white adipocyte differentiation
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
|
|
|
|
|
HNF4A and PNRC1 |
hepatocyte nuclear factor 4, alpha |
proline-rich nuclear receptor coactivator 1 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
|
|
|
|
|
HNF4A and MED7 |
hepatocyte nuclear factor 4, alpha |
mediator complex subunit 7 |
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
|
- PPARA activates gene expression
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- Generic Transcription Pathway
- Transcriptional regulation of white adipocyte differentiation
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
|
|
|
|
|